CABB catches SF-Chem in chlorine combo
German speciality chemicals firm CABB has scooped up Swiss company SF-Chem in a deal set to create a leading European supplier of chlorine and speciality intermediates.
Archives for July 22, 2007
Schering-Plough bolsters late-stage cardiac pipeline
Schering-Plough has licensed acadesine (AICA-riboside), a potential first-in-class drug for the prevention of ischemia-reperfusion injury from PeriCor Therapeutics to bolster its cardiac therapeutics pipeline.
PPD posts strong Q2 results, cuts year outlook
PPD has posted positive financial results for the second quarter of the year in net contrast to its lacklustre performance in Q1, but cut its earning outlook for the full year.
How flow rate can affect microfluidic cellular assays
UK researchers have shown that high fluid flow rates in microfluidic devices used for cellular assays can affect cell signalling channels and potentially interfere with drug screening results.
Novozymes awarded for animal-free innovation
Danish firm Novozymes has been honoured by animal rights organisation PETA for its efforts to provide animal-free bioprocessing methods aimed at cutting animal testing during drug development.